Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DRI Healthcare TrustDHTRF 33 Equity-to-Asset is 0.45 as of Jun. 2026, which is 25% below its 10-year median of 0.60. GuruFocus rates DHTRF with a GF Score™ of 33/100 and a GF Value™ of $14.33 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,008 Drug Manufacturers companies, DRI Healthcare Trust ranks worse than 69.94% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DRI Healthcare Trust's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $435.0 Mil. DRI Healthcare Trust's Total Assets for the quarter that ended in Jun. 2026 was $978.0 Mil.
Therefore, DRI Healthcare Trust's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.45.
The historical rank and industry rank for DRI Healthcare Trust's Equity-to-Asset or its related term are showing as below:
DHTRF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.45 Med: 0.6 Max: 0.88
Current: 0.45
During the past 5 years, the highest Equity to Asset Ratio of DRI Healthcare Trust was 0.88. The lowest was 0.45. And the median was 0.60.
DHTRF's Equity-to-Asset is ranked worse than 69.94% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs DHTRF: 0.45
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
DRI Healthcare Trust Equity-to-Asset Related Terms
DRI Healthcare Trust Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for DRI Healthcare Trust's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DRI Healthcare Trust Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where DRI Healthcare Trust's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
DRI Healthcare Trust's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRI Healthcare Trust (DHTRF) has a Equity-to-Asset of 0.45 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DRI Healthcare Trust and its competitors. This is 25% below median its historical median of 0.60. Over the past decade, DRI Healthcare Trust's Equity-to-Asset has ranged from 0.45 to 0.88. According to the industry distribution chart, DRI Healthcare Trust ranks #705 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 69.9%.
Is DRI Healthcare Trust's Equity-to-Asset too high?
DRI Healthcare Trust's current Equity-to-Asset of 0.45 is 25% below median its 10-year median of 0.60. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 0.88. The Drug Manufacturers industry median Equity-to-Asset is 0.60. DRI Healthcare Trust's value of 0.45 is 25% below this industry median. Based on the distribution chart, DRI Healthcare Trust ranks #705 out of 1008 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DRI Healthcare Trust has a GF Score™ of 33/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DRI Healthcare Trust's Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DRI Healthcare Trust ranks #705 out of 1008 companies for Equity-to-Asset. This places DRI Healthcare Trust in the lower half of its industry. The industry median Equity-to-Asset is 0.60. DRI Healthcare Trust's value of 0.45 is 25% below this benchmark. Historically, DRI Healthcare Trust's own Equity-to-Asset has ranged from 0.45 to 0.88 over the past decade. While the company's 10-year median is 0.60 vs. the industry median of 0.60, DRI Healthcare Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DRI Healthcare Trust's current Equity-to-Asset of 0.45 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DRI Healthcare Trust and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DRI Healthcare Trust's current Equity-to-Asset is 0.45, which is 25% below median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DRI Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, DRI Healthcare Trust (DHTRF) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.33, compared to a current price of $12.40 — trading 13.5% below its estimated fair value. The current Equity-to-Asset is 0.45, which is 25% below median its 10-year median of 0.60 and 25% below the Drug Manufacturers industry median of 0.60. DRI Healthcare Trust's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For DRI Healthcare Trust (DHTRF), the current Equity-to-Asset is 0.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DRI Healthcare Trust (DHTRF) Overvalued in 2026?
Based on GuruFocus' analysis, DRI Healthcare Trust stock appears to be undervalued.
The current stock price of $12.40 is trading 13.5% below its estimated GF Value™ of $14.33.
GuruFocus considers DRI Healthcare Trust to be Modestly Undervalued.
Key valuation signals for DHTRF:
Equity-to-Asset: 0.45 (25% below median its 10-year median of 0.60)
GF Value™: $14.33 vs. price of $12.40 (13.5% below fair value)
Industry Position: 25% below the Drug Manufacturers median (#705 of 1008)
No single metric tells the full story. See the DHTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
33GF Score
Get the complete analysis for DHTRF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHTRF has been successfully added to your 
